Hetero Labs Limited Cetirizine Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Cetirizine Export Records India — #8 Exporter, 395 Shipments, $7.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cetirizine

India Pharmaceutical Trade Intelligence

$178.2M649 Suppliers149 CountriesHS 30049031

ExportsIndia → UNITED STATES29.0%India → PHILIPPINES9.9%

ImportsUNITED STATES → India$46.2K CANADA → India$5.6K

#1 Supplier: FOURRTS (INDIA)#1 Buyer: M/S. DELMAW

Hetero Labs Limited — Cetirizine Exporter #8 | $7.5M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Cetirizine Exporter Profile

Indian Pharmaceutical Exporter · #8 for Cetirizine · $7.5M export value · DGFT Verified

Hetero Labs Limited is the #8 Indian exporter of Cetirizine with $7.5M in export value and 395 verified shipments. Hetero Labs Limited holds a 4.2% market share in Cetirizine exports across 31 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Cetirizine Export Profile: Buyers & Destinations

Hetero Labs Limited Cetirizine export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Cetirizine?

Country	Value	Shipments	Share
UNITED STATES	$2.7M	144	40.4%
CHILE	$2.7M	117	39.5%
MALTA	$205.9K	6	3.0%
GERMANY	$167.6K	4	2.5%
SAUDI ARABIA	$122.6K	12

Who Are the Top Buyers of Cetirizine from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	UNITED STATES	$3.4M	197
TO THE ORDER OF....	UNITED STATES	$626.4K	32
SEVEN PHARMA CHILE SPA	CHILE	$560.7K	18
TO THE ORDER OF:-.	CHILE	$508.2K	24
TO THE ORDER	THAILAND	$359.7K	27
M/S,	UNITED STATES	$108.4K	4
TO THE ORDER OF.,	UNITED ARAB EMIRATES	$104.4K	16
TO THE ORDER OF :	UNITED STATES	$79.1K	9
SAUDI AMAROX FOR INDUSTRY COMPANY	SAUDI ARABIA	$77.9K	5
MEDIS INTERNATIONAL A.S	GERMANY	$71.8K	2

Hetero Labs Limited supplies Cetirizine to 40 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by TO THE ORDER OF.... (UNITED STATES) and SEVEN PHARMA CHILE SPA (CHILE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cetirizine Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
LEVOCETIRIZINE TABLET	$986.1K	42
CETIRIZINE HCL ORAL SOLUTION 1MG/ML SOLU	$607.4K	34
LEVOCETIRIZINE 5MG TABLET	$517.9K	17
LEVOCETIRIZINE 5 MG TABS (TOTAL 162096 P	$300.0K	6
LEVOCETIRIZINE 5MG TABLET 10S	$265.2K	8
LEVOCETIRIZINE TABS	$186.0K	10
LEVOCETIRIZINE	$182.7K	9
LEVOCETIRIZINE ORAL SOLUTION 2.5MG/5ML (	$180.6K	13
LEVOCETIRIZINE TABLET 10S	$132.1K	11
LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE ORAL SOLUTION)	$128.2K	9

Hetero Labs Limited exports 136 distinct Cetirizine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEVOCETIRIZINE TABLET with 42 shipments worth $986.1K.

How Does Hetero Labs Limited Compare to Nearest Cetirizine Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	MARKSANS PHARMA LIMITED	$7.7M	338	6	$22.8K
7	J B CHEMICALS AND PHARMACEUTICALS LIMITED	$7.5M	172	3	$43.7K
8	HETERO LABS LIMITED ★	$7.5M	395	31	$18.9K
9	AUROBINDO PHARMA LTD	$6.7M	307	7	$21.8K
4	IPCA LABORATORIES LIMITED	$6.7M	134	12	$50.0K

Hetero Labs Limited ranks #8 among 649 Indian Cetirizine exporters. Average shipment value of $18.9K compared to the market average of $126.5K. The closest competitors by value are MARKSANS PHARMA LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Cetirizine Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	986	11.2%
JNPT/ NHAVA SHEVA SEA	731	8.3%
JNPT	616	7.0%
SAHAR AIR	542	6.2%
SAHAR AIR CARGO ACC (INBOM4)	491	5.6%
DELHI AIR CARGO ACC (INDEL4)	408	4.6%
DELHI AIR	381	4.3%
HYDERABAD ICD	374	4.3%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Cetirizine Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cetirizine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 395 individual customs records matching Hetero Labs Limited exporting Cetirizine, covering 136 formulations to 32 countries via 40 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 149+ countries, 1,814+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cetirizine

Cetirizine

Hetero Labs Limited — Cetirizine Exporter Profile

Hetero Labs Limited — Cetirizine Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Cetirizine?

Who Are the Top Buyers of Cetirizine from Hetero Labs Limited?

What Is India's Total Cetirizine Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Cetirizine Exports?

How Does Hetero Labs Limited Compare to Other Indian Cetirizine Exporters?

What Cetirizine Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Cetirizine to Key Markets

United States — FDA

How Does Hetero Labs Limited Compare to Nearest Cetirizine Exporters?

Which Indian Ports Ship Cetirizine Exports?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Cetirizine Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cetirizine Export Data from Hetero Labs Limited

Cetirizine Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source